PUBLICATION

Modular Bioorthogonal Lipid Nanoparticle Modification Platforms for Cardiac Homing

Authors
Cruz-Samperio, R., Hicks, C.L., Scott, A., Gispert Contamina, I., Elani, Y., Richardson, R.J., Perriman, A.W.
ID
ZDB-PUB-231010-55
Date
2023
Source
Journal of the American Chemical Society   145(41): 22659-22670 (Journal)
Registered Authors
Richardson, Rebecca, Scott, Aaron
Keywords
none
MeSH Terms
  • Animals
  • Fibronectins*
  • Liposomes
  • Nanoparticles*/chemistry
  • RNA, Small Interfering/chemistry
  • Zebrafish
PubMed
37812759 Full text @ J. Am. Chem. Soc.
Abstract
Lipid nanoparticles (LNPs) are becoming widely adopted as vectors for the delivery of therapeutic payloads but generally lack intrinsic tissue-homing properties. These extracellular vesicle (EV) mimetics can be targeted toward the liver, lung, or spleen via charge modification of their lipid headgroups. Homing to other tissues has only been achieved via covalent surface modification strategies using small-molecule ligands, peptides, or monoclonal antibodies─methods that are challenging to couple with large-scale manufacturing. Herein, we design a novel modular artificial membrane-binding protein (AMBP) platform for the modification of LNPs postformation. The system is composed of two protein modules that can be readily coupled using bioorthogonal chemistry to yield the AMBP. The first is a membrane anchor module comprising a supercharged green fluorescent protein (scGFP) electrostatically conjugated to a dynamic polymer surfactant corona. The second is a functional module containing a cardiac tissue fibronectin homing sequence from the bacterial adhesin CshA. We demonstrate that LNPs modified using the AMBP exhibit a 20-fold increase in uptake by fibronectin-rich C2C12 cells under static conditions and a 10-fold increase under physiologically relevant shear stresses, with no loss of cell viability. Moreover, we show targeted localization of the AMBP-modified LNPs in zebrafish hearts, highlighting their therapeutic potential as a vector for the treatment of cardiac disease and, more generally, as a smart vector.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping